P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 209 500 KRW -4.34% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

Operating Margin
PharmaResearch Co Ltd

34.5%
Current
34%
Average
-7.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
34.5%
=
Operating Profit
102.2B
/
Revenue
296.6B

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
KR
PharmaResearch Co Ltd
KOSDAQ:214450
2.2T KRW
34%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
300.2B USD
28%
US
Amgen Inc
NASDAQ:AMGN
159.1B USD
19%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD
40%
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD
38%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
137.3B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD
30%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
34.1B EUR
-22%
Country KR
Market Cap 2.2T KRW
Operating Margin
34%
Country FR
Market Cap 6T USD
Operating Margin
-17 527%
Country US
Market Cap 300.2B USD
Operating Margin
28%
Country US
Market Cap 159.1B USD
Operating Margin
19%
Country US
Market Cap 126.6B USD
Operating Margin
40%
Country US
Market Cap 114.6B USD
Operating Margin
38%
Country US
Market Cap 94.1B EUR
Operating Margin
-370%
Country AU
Market Cap 137.3B AUD
Operating Margin
26%
Country US
Market Cap 87.6B USD
Operating Margin
30%
Country US
Market Cap 39.3B EUR
Operating Margin
-33%
Country NL
Market Cap 34.1B EUR
Operating Margin
-22%

Profitability Report

View the profitability report to see the full profitability analysis for PharmaResearch Co Ltd.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
34.5%
=
Operating Profit
102.2B
/
Revenue
296.6B
What is the Operating Margin of PharmaResearch Co Ltd?

Based on PharmaResearch Co Ltd's most recent financial statements, the company has Operating Margin of 34.5%.